64,583 shares bought back at an average price of ₹262.49
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On October 28, 2026, the company bought back 64,583 fully paid equity shares of ₹2 each on the NSE through Emkay Global Financial Services. The average purchase price was ₹262.4914, excluding transaction costs. No shares were closed out, taking cumulative buybacks to 23,56,451 shares. No BSE purchases were reported.
The buyback reduces shares outstanding and may support the stock. No purchase-price premium can be assessed because the filing gives no market price comparison.